Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements

Author:

Cahyani InswastiORCID,Putro Eko W.,Ridwanuloh Asep M.,Wibowo SatrioORCID,Hariyatun Hariyatun,Syahputra Gita,Akbariani GilangORCID,Utomo Ahmad R.,Ilyas Mohammad,Loose Matthew,Kusharyoto Wien,Susanti Susanti

Abstract

Whole-genome sequencing (WGS) has played a significant role in understanding the epidemiology and biology of SARS-CoV-2 virus. Here, we investigate the use of SARS-CoV-2 WGS in Southeast and East Asian countries as a genomic surveillance during the COVID-19 pandemic. Nottingham–Indonesia Collaboration for Clinical Research and Training (NICCRAT) initiative has facilitated collaboration between the University of Nottingham and a team in the Research Center for Biotechnology, National Research and Innovation Agency (BRIN), to carry out a small number of SARS-CoV-2 WGS in Indonesia using Oxford Nanopore Technology (ONT). Analyses of SARS- CoV-2 genomes deposited on GISAID reveal the importance of clinical and demographic metadata collection and the importance of open access and data sharing. Lineage and phylogenetic analyses of two periods defined by the Delta variant outbreak reveal that: (1) B.1.466.2 variants were the most predominant in Indonesia before the Delta variant outbreak, having a unique spike gene mutation N439K at more than 98% frequency, (2) Delta variants AY.23 sub-lineage took over after June 2021, and (3) the highest rate of virus transmissions between Indonesia and other countries was through interactions with Singapore and Japan, two neighbouring countries with a high degree of access and travels to and from Indonesia.

Funder

Indonesian Endowment Fund (LPDP-RISPRO) grant scheme

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference67 articles.

1. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae)

2. Severe Acute Respiratory Syndrome (SARS)https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=tab_1

3. Middle East respiratory syndrome coronavirus (MERS-CoV)https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1

4. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19. 11 March 2020https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

5. Naming the Coronavirus Disease (COVID-19) and the Virus That Causes Ithttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3